 CARLSBAD, Calif., March 08, 2021 GLOBE NEWSWIRE -- Qualigen Therapeutics, Inc. NASDAQ: QLGN, a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that Michael Poirier, President, Chief Executive Officer and Chairman of Qualigen, will present at the Oppenheimer 31st Annual Healthcare Conference being held March 16-18 2021. 